The French government published a long-awaited decree this week detailing how a limited medical cannabis experiment will be carried out.
It was also confirmed that up to 3,000 patients will be able to participate in the experiment.
Participating companies will have to supply the medical cannabis products to patients free of charge, and the products will have to comply with pharmaceutical standards, including Good Manufacturing Practice.
The first prescriptions are now expected to occur in March 2021.
Continuer à lire sur Marijuana Business Daily.